Order results by:
| Issue | Title | |
| Vol 14, No 3 (2022) | Comorbidities and therapy for chronic non-specific low back pain and fibromyalgia | Abstract similar documents |
| T. I. Nasonova, E. V. Parfenova | ||
| "... to patients with chNLBP, significantly higher values of anxiety according to HADS (10.9±4.5 and 6.9±4.0 points ..." | ||
| Vol 12, No 2 (2020) | Myofascial pain syndrome in female patients with chronic nonspecific back pain: diagnosis and treatment | Abstract similar documents |
| D. O. Rozhkov, O. E. Zinovyeva, A. N. Barinov, I. M. Vikhlyantsev, G. Z. Mikhailova, N. V. Penkov, A. M. Nosovsky | ||
| "... concurrent with FJs; MFPS concurrent with SIJs. Twenty patients had MFPS only (its mean duration was 5.3±2 ..." | ||
| Vol 14, No 5 (2022) | Results of ELBRUS clinical non-interventional study | Abstract similar documents |
| D. O. Rozhkov, K. V. Shevtsova, V. V. Grinyuk, V. A. Parfenov | ||
| "... conducted. Patients received etoricoxib 60 mg once daily. Pain intensity was assessed on a 10-point ..." | ||
| Vol 16, No 3 (2024) | Rhythmic transcranial magnetic stimulation in the treatment of cervical dystonia and comorbid mental disorders | Abstract similar documents |
| A. A. Ragimova, D. S. Petelin, A. N. Galyautdinova, V. A. Tolmacheva, B. A. Volel | ||
| "... .01) and depression (from 8.4±3.7 to 5.2±3.2 points; p<0.01) on the HADS scale were noted, and a significant ..." | ||
| Vol 17, No 4 (2025) | The efficacy and safety of Dimephosphone in patients with chronic cerebral ischemia | Abstract similar documents |
| O. V. Ulyanova, T. I. Dutova | ||
| "... ), the Hospital Anxiety and Depression Scale (HADS), and the Tinetti scale. Results. A significant (p<0 ..." | ||
| Vol 15, No 6 (2023) | Chronic dizziness: modern treatment methods taking into account comorbidity | Abstract similar documents |
| E. N. Zastenskaia, L. M. Antonenko | ||
| "... .24 to 7.06±4.12 points (p<0.001), the severity of anxiety according to HADS from 13.47±4.16 to 8.60±2 ..." | ||
| Vol 12, No 6 (2020) | Nonsteroidal anti-inflammatory drugs, muscle relaxants, and B-group vitamins in the treatment of lumbar ischialgia | Abstract similar documents |
| V. A. Shirokov, A. V. Potaturko, N. L. Terekhov | ||
| "... ®) injected intramuscularly and into the trigger points in combination with tolperisone and B-group vitamins ..." | ||
| Vol 15, No 4 (2023) | Comorbid disorders and therapy of persistent postural perceptual dizziness | Abstract similar documents |
| E. N. Zastenskaya, L. M. Antonenko | ||
| "... to HADS decreased in the group with PPPD and ADD from 13.75±3.20 to 9.25±2.43 points (p<0 ..." | ||
| Vol 13, No 4 (2021) | Fatigue and cognitive impairment in post-COVID syndrome: possible treatment approaches | Abstract similar documents |
| A. N. Bogolepova, N. A. Osinovskaya, E. A. Kovalenko, E. V. Makhnovich | ||
| "... had ADDs (anxiety/depression level according to HADS ≥8 points; n=50) were prescribed with MexiB 6 (1 ..." | ||
| Vol 17, No 1 (2025) | Emotional disturbances in patients in the remote postoperative period after surgical treatment of cerebral aneurysms | Abstract PDF (Eng) similar documents |
| I. M. Shetova I.M, T. A. Shatokhin, V. A. Luk'yanchikov, A. A. Yakovlev, M. A. Piradov, V. V. Krylov | ||
| "... domain (using the HADS scale) were assessed. Results. In the remote postoperative period following ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Art therapy possibilities in the complex treatment of patients with multiple sclerosis | Abstract similar documents |
| M. E. Guseva, O. V. Matvievskaya, A. N. Boyko | ||
| "... age 32.9 years, mean EDSS severity 3.8 points) with MS underwent outpatient continuous active art ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Cognitive and emotional changes in patients with juvenile myoclonic epilepsy | Abstract similar documents |
| R. V. Magzhanov, D. V. Anisimova, P. N. Vlasov, V. A. Petrukhin, E. B. Tsevtsivadze, S. R. Nurmukhametova | ||
| "... and depression was assessed using the Hospital Anxiety and Depression Scale (HADS) and the Beck Depression ..." | ||
| Vol 8, No 2 (2016) | Effectiveness of prolonged-release melatonin in Improving Quality of Sleep in Patients Aged 55 or Over | Abstract similar documents |
| G. V. Kovrov, M. V. Agaltsov, Z. N. Sukmarova | ||
| "... test increased from 4 points at baseline to 5 points at the study end, p=0.0069). The drug had a good ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Analysis of migraine characteristics in postmenopausal women | Abstract similar documents |
| D. A. Klimentova, O. V. Kosivtsova, A. V. Sergeev, G. R. Tabeeva | ||
| "... , Migraine- ACT, MIDAS, SF-36, HADS, ISQ. The statistical analysis was performed in Microsoft Office Excel ..." | ||
| Vol 12, No 5 (2020) | The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease | Abstract similar documents |
| I. V. Miliukhina | ||
| "... rating scales, such as the Hospital Depression Scale (HADS-D), the Hospital Anxiety Scale (HADS ..." | ||
| Vol 16, No 5 (2024) | Efficacy and safety of cladribine tablets in multiple sclerosis in real-world clinical practice | Abstract similar documents |
| A. N. Peshkin, S. V. Kotov, G. T. Toniya, M. V. Sutormin, A. F. Eltayoury | ||
| "... men, mean age 36.4±9.3 years) with a disease duration of 2.2±1.5 years. Seven (9%) patients had ..." | ||
| Vol 12, No 6 (2020) | Mapping the limb muscle motor points for targeted administration of botulinum toxin in the treatment of focal and segmental spasticity | Abstract similar documents |
| A. P. Kovalenko, K. A. Sinelnikov, V. D. Shamigulov, N. N. Akhmedov, E. M. Shamina | ||
| "... injection of botulinum neurotoxin (BoNT) into the muscle motor points (MPs) is gaining more and more ..." | ||
| Vol 17, No 2 (2025) | Treatment of chronic cervicobrachialgia with the help of kinesiotherapy | Abstract similar documents |
| I. A. Strokov, A. A. Golovacheva, T. G. Fateeva | ||
| "... , and pain in the left shoulder with an intensity of up to 6 points on a numerical rating scale (NRS). He had ..." | ||
| Vol 15, No 6 (2023) | The use of inhaled nitric oxide (Tianox device) in patients with moderate cognitive impairment | Abstract similar documents |
| Yu. A. Starchina, D. A. Grishina, E. A. Sokolov, V. A. Parfenov | ||
| "... . The patients had from 7 to 10 inhalation sessions (the first, experimental – 20 minutes, the following sessions ..." | ||
| Vol 15, No 3 (2023) | Periarticular cysts of the cervical spine | Abstract similar documents |
| M. G. Bashlachev, G. Yu. Evzikov | ||
| "... .12 points according to VAS (p<0.01), disability according to DI decreased from 51.5±8.08 to 21.25± 4 ..." | ||
| Vol 11, No 4 (2019) | Target determination for transcranial magnetic stimulation in patients with a pharmacotherapy-resistant depressive episode based on the individual parameters of resting-state functional magnetic resonance imaging (a pilot blind controlled trial) | Abstract similar documents |
| A. G. Poydasheva, D. O. Sinitsyn, I. S. Bakulin, N. A. Suponeva, N. V. Maslennikov, E. E. Tsukarzi, S. N. Mosolov, M. A. Piradov | ||
| "... group, the target was located at a point within the left dorsolateral prefrontal cortex (DLPFC ..." | ||
| Vol 13, No 5 (2021) | Difficult issues in the management of patients with atrial fibrillation: a neurologist's point of view | Abstract PDF (Eng) similar documents |
| A. A. Kulesh | ||
| Vol 16, No 1 (2024) | A five-point scale for assessing the quality of life of patients with epilepsy | Abstract similar documents |
| P. N. Vlasov, V. A. Karlov, I. A. Zhidkova, A. O. Khabibova, A. M. Azhigova, V. A. Kharkovsky | ||
| "... considerable amount of time to complete them and then process. The five-point scale for assessing the QoL ..." | ||
| Vol 12, No 6 (2020) | Contemporary views of the mechanisms for development of myofascial pain syndrome and its treatment strategies | Abstract similar documents |
| G. R. Tabeeva, E. A. Kiryanova | ||
| "... and is characterized by the presence of a trigger point in the muscle involved in the pathological process. Clarifying ..." | ||
| Vol 6, No 3 (2014) | Myofascial pain: from Virchow's to our days | Abstract similar documents |
| I. V. Egorov | ||
| "... spasm and the presence of painful muscle infiltrations or local muscle hypertonus and trigger points ..." | ||
| Vol 3, No 1 (2011) | Experience in using intravenous thrombolysis in ischemic stroke in Tatarstan | Abstract similar documents |
| D. R. Khasanova, T. V. Demin | ||
| "... in 300 patients (188 men and 112 women) aged 21 to 79 years (mean age 59.8±13.7 years) who had ischemic ..." | ||
| Vol 16 (2024): (Suppl. 2) | High-dose immunosuppressive therapy followed by haematopoietic stem cell transplantation as a method for the treatment of refractory forms of neuromyelitis optica spectrum disorder in children | Abstract similar documents |
| N. N. Bronina, O. V. Bykova, G. O. Bronin, A. E. Kessel, G. Z. Seregin, K. I. Kirgizov, A. Yu. Polushin, T. T. Batysheva | ||
| "... ’s neurological deficit progressed to 9.5 points on the Expanded Disability Status Scale (EDSS). After ..." | ||
| Vol 3, No 2 (2011) | Therapy of depression in patients with focal epilepsy: experience with citalopram use | Abstract similar documents |
| A. V. Lebedeva, E. G. Melikyan, A. B. Gekht | ||
| "... to have varying symptoms of depression. The Hospital Anxiety and Depression Scale (HADS) was used ..." | ||
| Vol 17, No 1 (2025) | Thrombolytic therapy with Revelisa in ischemic stroke: results of the PRIMA international multicenter observational study | Abstract similar documents |
| N. A. Shamalov, D. R. Khasanova, S. V. Marchenko, M. A. Soldatov, T. P Alekseeva, O. V. Androfagina, L. N. Antipova, L. I. Anishchenko, E. M. Beketova, A. A. Bulanov, A. V. Gerasimova, N. Kh. Gorst, A. G. Gutsalyuk, T. V. Demin, A. V. Dyudin, U. A. Yelemanov, A. R. Zakaryaeva, N. N. Zinovyeva, S. S. Ziborova, D. N. Kazakov, N. V. Komissarova, I. V. Korobeynikov, K. V. Korovashkova, E. L. Kuzmin, A. A. Kulesh, R. R. Kuliev, A. S. Lebedev, A. L. Lukyanov, V. I. Maksimov, O. I. Mikhaylenko, I. V. Moldavskaya, D. M. Murtazalieva, Yu. S. Mukhamadieva, V. N. Nesterova, D. G. Novikov, S. V. Platunova, E. P. Prudius, R. A. Rayemgulov, V. A. Saskin, A. V. Sinelshchikova, E. A. Strautmanis, V. S. Suryakhin, E. V. Tavlueva, Yu. A. Telyatnik, N. V. Halo, M. S. Cherepyansky, N. A. Marskaya | ||
| "... . Results. An improvement of 4 points or more on the NIHSS scale one day after TLT was observed in 41 ..." | ||
| Vol 16, No 1 (2024) | Safety and efficacy of fremanezumab in real clinical practice in patients with chronic migraine | Abstract similar documents |
| G. N. Belskaya, A. V. Krasnikov, E. A. Kiryanova, M. E. Prokopovich, E. V. Sakharova, G. V. Makarov | ||
| "... by 11.6 per month, with monthly injections – by 12.6 per month (p<0.01). In patients who had negative ..." | ||
| Vol 15, No 6 (2023) | NOVEMA® NIGHT (diphenhydramine + naproxen) in patients with pain and insomnia: results of a multicenter non-interventional observational study | Abstract similar documents |
| A. B. Danilov, A. A. Pilipovich, M. V. Pyastolova | ||
| "... before and after treatment; QoL was assessed after treatment using a five-point scale. Results. During ..." | ||
| Vol 16, No 3 (2024) | Impact of COVID-19 on mild vascular cognitive impairment in patients with atrial fibrillation: results of a three-year observational study | Abstract similar documents |
| O. V. Vorob'eva, N. N. Shindryaeva, V. V. Fateeva | ||
| "... .5% of patients had documented SARS-CoV-2-associated pneumonia. During the observation period, patients received ..." | ||
| Vol 16, No 4 (2024) | Kinesiotherapy in painful diabetic polyneuropathy | Abstract similar documents |
| E. V. Mandra, V. A. Parfenov, L. T. Akhmedzhanova, E. S. Shulakova, V. V. Fadeev, M. V. Amosova | ||
| "... .07 ± 1.91 points respectively), neuropathic pain according to NTSS-9 (13.65 ± 4.54 and 11.79 ± 5 ..." | ||
| Vol 13, No 4 (2021) | Rehabilitation of patients after lumbar microdiscectomy | Abstract similar documents |
| V. S. Prokopovich, V. A. Parfenov | ||
| "... in pain intensity - up to 4 points on the VAS, and an improvement in activities of daily living up to 10 ..." | ||
| Vol 15, No 5 (2023) | Comprehensive diagnosis of cervical dystonia and the efficacy of long-term (three-year) botulinum therapy | Abstract similar documents |
| V. A. Tolmacheva, D. S. Petelin, B. A. Volel | ||
| "... . The severity of the disease before BT was 36.71±3.6 points. The control group consisted of 46 healthy subjects ..." | ||
| Vol 15, No 2 (2023) | Quality of life of patients with rheumatoid arthritis and comorbid fibromyalgia | Abstract similar documents |
| N. A. Melikova, E. S. Filatova, E. G. Filatova, A. M. Lila | ||
| "... and severity of fatigue (FSS), anxiety and depression (HADS), sleep disorders (PSQI), cognitive impairment ..." | ||
| Vol 15, No 3 (2023) | Impact of depression on the quality of life of patients with multiple sclerosis | Abstract similar documents |
| N. V. Zarubina, N. N. Spirin | ||
| "... .45 points, the average duration of the disease was 8.07±7.22 years. The comparison group consisted of 52 ..." | ||
| Vol 14, No 1 (2022) | The efficacy and safety of ipidacrine in patients with idiopathic neuropathy of the facial nerve (PELICAN study) | Abstract similar documents |
| I. N. Samartsev, S. A. Zhivolupov, V. V. Ponomarev, M. N. Markova, K. R. Magomedov | ||
| "... (HouseBrackmann – 1.9±0.7 points, FaCE – 78±11.8 points; p<0.05). There were no intergroup differences in the SAQ ..." | ||
| Vol 12, No 6 (2020) | Cognitive and emotional impairment in patients with migraine and signs of leukoencephalopathy during preventive therapy | Abstract similar documents |
| K. A. Pozhidaev, V. A. Parfenov | ||
| "... for Epidemiological Studies Depression Scale (CES-D); the Hospital Anxiety and Depression Scale (HADS ..." | ||
| Vol 11, No 3 (2019) | Rehabilitation in acute stroke from the point of view of evidence-based medicine: possibilities of drug treatment | Abstract similar documents |
| A. A. Kulesh | ||
| Vol 16, No 6 (2024) | Antidepressant and anxiolytic efficacy and tolerability of agomelatine in the treatment of depression after COVID-19 in daily clinical practice (non-interventional study TELESPHOR) | Abstract similar documents |
| V. E. Medvedev, A. N. Bogolepova, D. P. Morozov, B. B. Kvasnikov | ||
| "... .6 points – by 2.6±3.3, 6.7±5.3 and 10.9±4.9 points, respectively, compared to baseline (p<0.0001 for all ..." | ||
| Vol 13, No 6 (2021) | Impact of the physical rehabilitation onset time in early recovery period of ischemic stroke (second stage of medical rehabilitation) on the level of daily activity and independence | Abstract similar documents |
| S. V. Kotov, L. H. Kodzokova, E. V. Isakova, A. S. Kotov | ||
| "... -term disability. Until now, there is no single point of view on when the second stage of medical ..." | ||
| Vol 16, No 2 (2024) | Effects of rehabilitation on functional independence in daily life, exercise tolerance and quality of life in patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| Ya. G. Pekhova, M. Yu. Martynov, I. A. Belayeva, A. S. Ryabov, A. A. Vershinin, A. N. Boiko | ||
| "... and 5 men; age – 41.6±7.7 years; EDSS – 4.0 [3.5; 5.0] points, duration of MS – 8.0 [3.0; 21.0] years ..." | ||
| Vol 17, No 2 (2025) | Use of botulinum toxin in patients with dysphagia and sialorrhea in acute ischemic stroke | Abstract PDF (Eng) similar documents |
| V. V. Gusev, T. V. Balueva, O. V. Zayceva, D. A. Smirnov | ||
| "... group at baseline had severe dysphagia according to PAS, FEDSS and CIB dysphagia scales (5.88±1.37; 4 ..." | ||
| Vol 16, No 3 (2024) | Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra | Abstract similar documents |
| A. A. Sokolova, L. I. Anischenko, L. S. Zemlyanushin, E. A. Rubtsova | ||
| "... . Before starting treatment with cladribine tablets, only six (11%) out of 54 patients had no exacerbations ..." | ||
| Vol 14, No 2 (2022) | Possibilities nootropic drugs in non-demented patients with vascular cognitive disorders | Abstract similar documents |
| M. N. Dadasheva, R. V. Gorenkov, V. A. Kruglov, K. N. Dadasheva, D. I. Lebedeva | ||
| "... from 19.8 to 23.3 points (p≥0.001) was observed in the omberacetam group. In other groups, an increase ..." | ||
| Vol 14, No 3 (2022) | Anamnestic, clinical and laboratory features of the acute period of ischemic stroke in young patients | Abstract PDF (Eng) similar documents |
| V. V. Gusev, O. P. Kovtun, O. A. Lvova, E. A. Partylova, A. P. Sergeev, M. V. Sergeeva, I. T. Yanchuk, D. A. Dobrazova, P. A. Suvorkov, N. A. Shamalov | ||
| "... and methods. Clinical and statistical processing of data of 256 patients aged 18 to 44 years included, who had ..." | ||
| Vol 16, No 1 (2024) | Treatment of cognitive impairment in patients with cerebral infarction in the internal carotid arteries circulation system: results of a multicentre, randomized, double-blind, placebo-controlled clinical trial | Abstract similar documents |
| D. R. Khasanova, A. A. Yakupova, P. R. Kamchatnov, Zh. Yu. Chefranova, E. I. Bogdanov, P. I Pilipenko, N. M. Khasanova | ||
| "... points on the Montreal Cognitive Assessment, MoCA), full consciousness (15 points on the Glasgow Coma ..." | ||
| Vol 14, No 2 (2022) | Muscular factor in the development of musculoskeletal pain. Treatment options | Abstract similar documents |
| A. I. Isaikin, T. I. Nasonova | ||
| "... . The hypothesis of the leading role of myofascial trigger points (MTPs) in muscle pain remains debatable. Probably ..." | ||
| Vol 9, No 2 (2017) | Role of a muscle factor in the development of low back pain | Abstract similar documents |
| A. I. Isaikin, G. E. Shevtsova, D. O. Rozhkov, A. V. Kavelina, M. A. Ivanova | ||
| "... of myofascial trigger points (MTP). MFPS most frequently occurs in patients with neck pain. The peripheral ..." | ||
| Vol 14, No 2 (2022) | Post-COVID pain syndrome: a review of international observations | Abstract similar documents |
| O. A. Shavlovskaya, I. A. Bokova, N. I. Shavlovskiy | ||
| "... of moderate severity (≥3 points on the visual analog scale). Patients with new-onset pain during COVID had ..." | ||
| Vol 14, No 4 (2022) | Effect of statins on oxidative stress and cognitive function in patients with cerebral atherosclerosis: results of a prospective cohort study | Abstract similar documents |
| K. V. Nikulina, O. V. Vorobieva, V. V. Fateeva | ||
| "... as a significant increase in attention- (by 1.5 points versus 0.1 points; p<0.05) and memory- (by 0.9 points ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Clinical and psychoemotional characteristics of patients with medication overuse headache | Abstract similar documents |
| E. A. Guziy, A. V. Sergeev, G. R. Tabeeva | ||
| "... . The study showed that 100% of patients with CM and MOH had various psychoemotional disorders. At the same ..." | ||
| Online-first | Прогностическая значимость умеренных когнитивных нарушений у пациентов с высоким и очень высоким кардиоваскулярным риском | Abstract similar documents |
| В. В. Генкель, А. С. Кузнецова, А. О. Салашенко, Е. В. Лебедев, И. И. Шапошник | ||
| "... (63,9%) patients scored ≥28 points on the MMSE scale. Mild cognitive impairment (MCI) were detected ..." | ||
| Vol 10, No 3 (2018) | Correlation of the aesthetic component of dental health and emotional state in patients with different anxiety levels | Abstract similar documents |
| O. I. Lobach, V. N. Nikolenko, E. K. Rustamova, N. V. Lapina, E. V. Kochurova, L. A. Skorikova, L. V. Gavrushova | ||
| "... patients aged 60 to 67 years who had a poor aesthetic appearance of the hard tissues of the front teeth ..." | ||
| Vol 16, No 5 (2024) | Brain-computer interfaces based on near-infrared spectroscopy and electroencephalography registration in post-stroke rehabilitation: a comparative study | Abstract PDF (Eng) similar documents |
| O. A. Mokienko, R. Kh. Lyukmanov, P. D. Bobrov, M. R. Isaev, E. S. Ikonnikova, А. N. Cherkasova, N. A. Suponeva, M. A. Piradov | ||
| "... .0 [2.0; 10.0] months; upper limb paresis – 47.0 [35.0; 54.0] points on the Fugl-Meyer Assessment ..." | ||
| Vol 9, No 4 (2017) | The course of cervical dystonia with head tremor during botulinum toxin type A treatment | Abstract similar documents |
| A. N. Korenko, A. A. Skoromets, A. A. Timofeeva, A. V. Tishkov | ||
| "... . At the same type, 18 of these patients received 4 cycles of injections and 36 patients had 8 cycles ..." | ||
| Vol 8, No 2 (2016) | Treatment for mixed cognitive impairments and emotional disorders in young and middle-aged patients | Abstract similar documents |
| V. A. Parfenov, E. Yu. Solovyeva, L. M. Antonenko, A. B. Lokshina, T. Gorskaya | ||
| "... education in the efficacy of Tanakan®. Conclusion. Tanakan® had a very good safety profile; no adverse drug ..." | ||
| Vol 14, No 3 (2022) | The prevalence of cognitive impairment and their association with socioeconomic, demographic and anthropometric factors and geriatric syndromes in people over 65 years of age: data from the Russian epidemiological study EVKALIPT | Abstract PDF (Eng) similar documents |
| E. A. Mkhitaryan, N. M. Vorobieva, O. N. Tkacheva, Yu. V. Kotovskaya, N. N. Koberskaya, E. V. Selezneva, L. N. Ovcharova | ||
| "... .8% of the subjects, and severe disorders – in 19.9% (0 or 1 point according to the mini-Cog). Patients with CI had ..." | ||
| Vol 13, No 4 (2021) | IncobotulinumtoxinA in the treatment of sialorrhea in patients with infantile cerebral palsy | Abstract similar documents |
| A. L. Kurenkov, L. M. Kuzenkova, V. V. Chernikov, B. I. Bursagova, A. A. Nezhelskaya, A. R. Artemenko | ||
| "... injections, which was demonstrated by a reduction in mean DIS score from 78.6±9.6 (min 62, max 95 points; 95 ..." | ||
| Vol 11, No 3 (2019) | Early cognitive dysfunction as a marker for the poor course of multiple sclerosis: a prospective 12-year follow-up | Abstract similar documents |
| D. S. Kasatkin, S. S. Molchanova, N. N. Spirin | ||
| "... and decreased attentional function (failure to complete more than 25% of the PASAT tasks) had a significantly ..." | ||
| Vol 12, No 1 (2020) | Experience with vortioxetine in the treatment of post-stroke depression | Abstract similar documents |
| I. A. Strelnikova, A. A. Svetkina, Yu. D. Minina, O. V. Androfagina | ||
| "... of depression using the Hospital Anxiety and Depression Scale (HADS) and MADRS and cognitive functions ..." | ||
| Vol 10, No 3 (2018) | Effect of mexidol on the efficiency of intravenous thrombolytic therapy for ischemic stroke during the therapeutic window | Abstract similar documents |
| K. S. Knni, T. V. Dyomin, L. B. Adeeva | ||
| "... enrolled 123 patients with ischemic stroke (IS) who had undergone intravenous TLT in the vascular centers ..." | ||
| Vol 15, No 2 (2023) | Patient with non-cardioembolic ischemic stroke or high-risk transient ischemic attack. Part 1. Diagnosis | Abstract similar documents |
| A. A. Kulesh, S. N. Yanishevsky, D. A. Demin, L. I. Syromyatnikova, O. I. Vinogradov | ||
| "... : those with an ABCD2 score of ≥4 points or an ABCD3-I score of ≥8 points; with TIA in the vertebrobasilar ..." | ||
| Online-first | From pathogenesis and research to the treatment of secondary progressive multiple sclerosis in clinical practice: switching from anti-CD20 monoclonal antibody therapy to siponimod (clinical case) | Abstract similar documents |
| E. V. Popova | ||
| "... progression on the EDSS scale from 4.5 to 6.0 points over 3 years of therapy. In this regard, the patient ..." | ||
| Vol 11, No 1 (2019) | Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis | Abstract PDF (Eng) similar documents |
| O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko | ||
| "... with PPMS showed stabilization of EDSS score; and 6 (50%) had even its slight decrease by 0.5–1.0 scores ..." | ||
| Vol 8, No 1 (2016) | SNAP-25 gene polymorphism and cognitive resource in patients with stroke sequels | Abstract similar documents |
| V. B. Vilyanov, G. N. Kobozev | ||
| "... patients who had experienced IS (n=116) or HS (n=72) were examined. The SNAP-25 gene polymorphisms rs ..." | ||
| Vol 9, No 1 (2017) | The impact of sleep-disordered breathing on early functional recovery in ischemic stroke | Abstract similar documents |
| G. M. Lutokhin, L. A. Geraskina, A. V. Fonyakin, M. Yu. Maksimova | ||
| "... , and incidence of cardiac pathology. At the same time, at baseline Group 2 had a more severity of neurological ..." | ||
| Vol 15, No 3 (2023) | Clinical effectiveness and safety of prolonged release form of alimemazine in patients with generalized anxiety disorder | Abstract similar documents |
| Ju. E. Azimova, Yu. P. Sivolap, K. A. Ishchenko | ||
| "... (Visit 1) was 24.8±7.3 points. Results. By Week 6, the level of anxiety statistically significantly ..." | ||
| Vol 11, No 4 (2019) | Prognostic significance of moderate cognitive impairment in patients at high and very high cardiovascular risk | Abstract similar documents |
| V. V. Henkel, A. S. Kuznetsova, A. O. Salashenko, E. V. Lebedev, I. I. Shaposhnik | ||
| "... . The Kaplan-Meier analysis showed that patients with MCI (24–27 MMSE scores) had a significantly lower >2-year ..." | ||
| 1 - 70 of 421 Items | 1 2 3 4 5 6 7 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
